SCHEMBL21028378

SCHEMBL21028378

CC(C)c1ccc(S(=O)(=O)N[C@@H](C)C(F)(F)F)cc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 3/20 0.45
CCR2 P41597 5/20 0.39
NPSR1 Q6W5P4 1/20 0.38
NOTUM Q6P988 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MMP7 P09237 2/20 0.37
KIF11 P52732 1/20 0.37
NR3C1 P04150 1/20 0.36
PGR P06401 1/20 0.36
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
MMP9 P14780 1/20 0.36
MMP13 P45452 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
MEP1B Q16820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16852788 0.84 RORC (0.41) RORCCCR2NPSR1CA1CA2
SCHEMBL17710000 0.83 RORC (0.41) RORCCCR2NPSR1CA1CA2
SCHEMBL17709999 0.83 RORC (0.41) RORCCCR2NPSR1CA1CA2
SCHEMBL16849222 0.83 ALDH1A1 (0.43) RORCCCR2NPSR1CA1CA2
SCHEMBL21028143 0.83 RORC (0.41) RORCNPSR1CA1CA2MMP7
SCHEMBL21028141 0.82 RORC (0.42) RORCCCR2NPSR1CA1CA2
SCHEMBL21028254 0.81 SMN1; SMN2 (0.50) RORCCCR2NOTUMKIF11POLB
SCHEMBL21028211 0.80 RORC (0.41) RORCNPSR1
SCHEMBL21028212 0.79 ALDH1A1 (0.39) RORCNPSR1CA1CA2POLB
SCHEMBL15035938 0.79 KIF11 (0.47) RORCCCR2NOTUMKIF11PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] PHENEX PHARMACEUTICALS AG (DE) 2019-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] RORA, RORB, RORC RORC 3/4885CCR2 814/4885NPSR1 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.